Experimental diabetes drug could help fight Alzheimer's disease

September 14, 2012

(Medical Xpress)—A drug designed for diabetes sufferers could have the potential to treat neurodegenerative diseases like Alzheimer's, a study by scientists at the University of Ulster has revealed.

Type II diabetes is a known risk factor for Alzheimer's and it is thought that impaired insulin signalling in the brain could damage nerve cells and contribute to the disease.

Scientists believe that drugs designed to tackle could also have benefits for keeping our healthy.

To investigate this, Prof Christian Hölscher and his team at the Biomedical Sciences Research Institute on the Coleraine campus used an called (Val8)GLP-1.

This drug simulates the activity of a protein called GLP-1, which can help the body control its response to blood sugar. The scientists treated healthy mice with the drug and studied its effects in the brain.

Although it is often difficult for drugs to cross from the blood into the brain, the team found that (Val8)GLP-1 entered the brain and appeared to have no side-effects at the doses tested.

The drug promoted new brain cells to grow in the , an area of the brain known to be involved in memory. This finding suggests that as well as its role in insulin signalling, GLP-1 may also be important for the production of new nerve cells in the .

The team found that blocking the effect of GLP-1 in the brain made mice perform more poorly on learning and , while boosting it with the drug seemed to have no effect on behaviour.

The new findings, published this week in the journal , are part of ongoing research funded by Alzheimer's Research UK, the leading dementia research charity.

Prof Hölscher, said: "Here at the Biomedical Sciences Research Institute, we are really interested in the potential of for protecting brain cells from damage and even promoting new brain cells to grow. This could have huge implications for diseases like Alzheimer's or Parkinson's, where brain cells are lost.

"It is very encouraging that the experimental drug we tested, (Val8)GLP-1, entered the brain and our work suggests that GLP-1 could be a really important target for boosting memory. While we didn't see benefits on in these healthy mice, we are keen to test the drugs in mice with signs of Alzheimer's disease, where we could see real improvements."

Dr Simon Ridley, Head of Research at Alzheimer's Research UK, said: "We are pleased to have supported this early stage research, suggesting that this experimental diabetes drug could also promote the growth of new brain cells. While we know losing brain cells is a key feature of Alzheimer's, there is a long way to go before we would know whether this drug could benefit people with the disease.

"This research will help us understand the factors that keep healthy, knowledge that could hold vital clues to tackling Alzheimer's. With over half a million people in the UK living with the disease, learning more about how to keep our brain cells healthy is of vital importance. Funding for dementia research lags far behind that of other common diseases, but is essential if we are to realise the true potential of research like this."

The Biomedical Science Research Institute (BMSRI) in Coleraine, is one of 15 University Research Institutes at Ulster and ranked second in the UK in the last national Research Assessment Exercise in 2008.

The BMSRI has been conducting pioneering research to investigate the underlying causes, diagnosis, treatment and prevention of human degenerative diseases."

Explore further: Cholesterol drug shows benefit in animal study of Alzheimer's disease

Related Stories

Cholesterol drug shows benefit in animal study of Alzheimer's disease

April 3, 2012
A cholesterol drug commonly prescribed to reduce cardiovascular disease risk restores blood vessel function in a mouse model of Alzheimer's disease, according to a study in the April 4 issue of The Journal of Neuroscience. ...

Diabetes drug metformin makes brain cells grow

July 5, 2012
The widely used diabetes drug metformin comes with a rather unexpected and alluring side effect: it encourages the growth of new neurons in the brain. The study reported in the July 6th issue of Cell Stem Cell also finds ...

Recommended for you

Dementia with Lewy bodies: Unique genetic profile identified

December 15, 2017
Dementia with Lewy bodies has a unique genetic profile, distinct from those of Alzheimer's disease or Parkinson's disease, according to the first large-scale genetic study of this common type of dementia.

Major cause of dementia discovered

December 11, 2017
An international team of scientists have confirmed the discovery of a major cause of dementia, with important implications for possible treatment and diagnosis.

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Argiod
not rated yet Sep 14, 2012
Is the University looking for research volunteers (human guinea pigs)? I have a friend whose lady is well along in her Alzheimer's. If he can't get any help soon, he'll have to have her put into a full-care facillity; as he is not able to keep up with her constant needs...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.